---
title: "ZHAOKE OPHTH (6622) expects three products to be approved successively this year"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/281483179.md"
description: "ZHAOKE OPHTH Chairman Li Xiaoyi expects that in the second half of this year, multiple products will be approved one after another, including atropine sulfate eye drops for controlling myopia in adolescents, cyclosporine eye gel for treating dry eye syndrome, and bevacizumab intravitreal injection. In addition, the group plans to expand its international network to Latin America or South America"
datetime: "2026-04-02T07:32:22.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/281483179.md)
  - [en](https://longbridge.com/en/news/281483179.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/281483179.md)
---

# ZHAOKE OPHTH (6622) expects three products to be approved successively this year

ZHAOKE OPHTH (6622.HK) Chairman, Executive Director, and CEO Li Xiaoyi expects that in the second half of this year, multiple products under the group will be approved for application successively, hoping to expand the international network to Latin America or South America this year.

The products approved for listing this year include two dosages of atropine sulfate eye drops 0.01% and 0.02% used to control the progression of myopia in adolescents, as well as cyclosporine eye gel for the treatment of dry eye syndrome, and bevacizumab intravitreal injection

### Related Stocks

- [06622.HK](https://longbridge.com/en/quote/06622.HK.md)

## Related News & Research

- [Zhaoke Ophthalmology Shareholders Approve All Resolutions at 2026 AGM](https://longbridge.com/en/news/286577328.md)
- [12:46 ETEyePromise Introduces Heyedrate™ Clinical: A Next Generation Artificial Tear](https://longbridge.com/en/news/286800296.md)
- [05:20 ETThrough the America's Most Artistic Kid Competition, Colossal Raises $1.6 Million While Celebrating the Next Gen of Creative Visionaries](https://longbridge.com/en/news/287037755.md)
- [DJI’s e-bike division tries to defend why its motors are so insanely powerful](https://longbridge.com/en/news/286894898.md)
- [AIA Singapore targets 90% of illness claims](https://longbridge.com/en/news/287132135.md)